Home/Filings/4/0001209191-21-049605
4//SEC Filing

Andrews William T. 4

Accession 0001209191-21-049605

CIK 0001419600other

Filed

Aug 3, 8:00 PM ET

Accepted

Aug 4, 4:09 PM ET

Size

7.3 KB

Accession

0001209191-21-049605

Insider Transaction Report

Form 4
Period: 2021-08-02
Andrews William T.
Chief Medical Officer
Transactions
  • Award

    Stock option (right to buy)

    2021-08-02+205,500205,500 total
    Exercise: $6.25Exp: 2031-08-01Common Stock (205,500 underlying)
  • Award

    Common Stock

    2021-08-02+34,25034,250 total
Footnotes (2)
  • [F1]Represents a restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan.
  • [F2]25% of the shares subject to the option shall vest on the one-year anniversary of July 1, 2021 (the "Vesting Commencement Date"), and 1/48th of the shares subject to the option shall vest each month following the one-year anniversary of the Vesting Commencement Date, so that all of the shares subject to the options shall be vested four years after the Vesting Commencement Date.

Issuer

Flexion Therapeutics Inc

CIK 0001419600

Entity typeother

Related Parties

1
  • filerCIK 0001638459

Filing Metadata

Form type
4
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 4:09 PM ET
Size
7.3 KB